Clinical Trials Browser

Phase 2 × Has results × Interleukins × Clear all

NCT00994643 2025-04-30

Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma

Phase 2 Completed

11 enrolled 9 charts

Lymphoma, Lymphoma, Non-Hodgkin